Skip to content

Efficacy of NSF on acute stress

Efficacy of NSF on acute stress - NMC1-2017

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
DRKS
Registry ID
DRKS00012868
Enrollment
20
Registered
2017-08-11
Start date
2017-08-09
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress

Interventions

Group 1: Treatmentgroup NSF (No Stress Flash - active ingredients: Lactium und ETAS) on visit 1 and 2 respectively 2 tablets, oral, controlled intake. Group 2: Placebogroup From a previous study with

Sponsors

NMC Lab SAS
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: healthy; pre-menopausal women must use hormonal contraception (for 3 months or more)

Exclusion criteria

Exclusion criteria: - smoker (> 5 cigarettes / day) - any known allergies to the test substances - any known addiction to drugs and alcohol - hyper- or hypotension (except for those whose blood pressure is stable using medication for more than 3 months) - known hyper- or hypothyroidism unless treated and under control (stable for more than 3 months) - intake of dietary supplements or homoeopathic remedies during 2 weeks before V1 - on a strict diet or practicing sport, extensively - any other known current/acute or chronic physical or psychological diseases besides minor medical conditions (e.g. seasonal allergies) - subjects having previously participated in the TSST - pregnant or lactating females or females planning a pregnancy within the next 3 months - post-menopausal women using hormonal medication for less than 3 months - employee of the sponsor or Clinical Research Organization (CRO) - Investigator doubts truthfulness of self-reported health information - not suitable because of limited verbal and cognitive abilities - on vacation within the last 2 weeks

Design outcomes

Primary

MeasureTime frame
Primary Endpoint of the Study is to evaluate the efficacy of NSF on acute stress. Efficacy is defined as a dampened cortisol increase in response to the TSST and as compared to a matched control population. The TSST (Trier Social Stress Test) takes place on visit 2 and 6 saliva samples are collected in total (TSST - 2min, TSST + 1min, + 10min, + 20min, + 30min, + 45min).

Secondary

MeasureTime frame
Secondary Endpoints: Efficacy of NSF on acute stress: - subjective stress, subjective anxiety and subjetive insecurity as measured by VAS-Scales before, during and after the TSST - heartrate during an acute stressful situation - blood pressure during an acute stressful situation

Countries

Germany

Contacts

Public ContactJuliane Hellhammer

daacro GmbH & Co. KG

info@daacro.de+ 49 (0) 651 9120 494

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026